JPRN-C000000313已完成未知
A dose comparing study of peginterferon alfa-2b plus ribavirin in chronic hepatitis type C except genotype 1 and high pretreatment viremia.: A randomized open-label pilot study. - peginterferon alfa-2b plus ribavirin combination therapy for chronic hepatitis C except genotype 1 and high pretreatment viremia.
Hiroshima liver study group0 个研究点目标入组 120 人开始时间: 2006年1月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients receiving shosaiko-to 2)Autoimmune hepatitis 3)History of hypersensitivity to PEG-IFN alpha-2b or other interferons 4)History of hypersensitivity to biological products such as vaccine 5)Decompenstated liver cirrhosis 6)HCC, malignat tumor 7)With or with a history of severe psychosis such as severe depression, suicidal ideation or attempt, etc. 8)Pregnant or lactating women and women who may be pregnant 9)Judged by investigator not to be appropriate for inclusion in this study
研究者
相似试验
进行中（未招募）
不适用
A Single Dose Study to Assess the Biocomparison of MK-8669 in SubjectsSarcomaEUCTR2011-003433-33-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.21
尚未招募
4 期
Comparative outcome in different dosage of intra-articular steroid injection for symptomatic osteoarthritis of hip, a randomized control trial of multicenter studyHip steroid injectionHip osteoarthritisTCTR20220301001Thai Orthopedic Society for Sports Medicine (TOSSM)130
已完成
3 期
The effects of two different doses dexmedetomidine after Endotracheal intubatioIRCT20160307026950N15Esfahan University of Medical Sciences90
终止
2 期
Cemdisiran and eculizumab dose-ranging study for paroxysmal nocturnal haemoglobinuriaParoxysmal nocturnal haemoglobinuria (PNH)Haematological DisordersParoxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]ISRCTN31882639niversity of Leeds9
进行中（未招募）
不适用
This is a clinical study designed to explore the safety, effectiveness and optimum dose of the medicine MED-563 in adult patients who suffer from asthma that is not fully controlled by other treatmentsncontrolled AsthmaMedDRA version: 14.0Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2010-020126-17-BGAstraZeneca AB482